However, in our study, Fh15 was administered intraperitoneally (i.p.)concurrently with colitis induction, whereas in other studies, treatments with GST28, TsSp, or Al-CPI were administered prophylactically via subcutaneous or intraperitoneal (i.p.)routes several days or weeks before colitis induction. This evidence concerns the gene PRSS16 and colitis.